🔓 Unlock the full profile of Judson Ivy (Ensemble Health Partners), including verified contact details, financial insights, and professional associations.
See Judson Ivy Full ProfileBelow are the ✅ Verified Contact Details to help you connect directly:
Email: jud*****@ens******.com
Mobile: 63140*****
Estimated Net Worth 💰 : ₹0 – ₹500+ Cr (approx. $0 – $60M)
Key Insights You Should Know About This Individual
- Judson Ivy founded Ensemble Health Partners in March 2014, establishing a company focused on enhancing healthcare financial performance and patient engagement.
- Under Ivy's leadership as Founder and CEO, Ensemble Health Partners has experienced significant growth, with a reported headcount increase of over 10% in the past two years.
- Ensemble Health Partners operates in the healthcare space, offering services related to revenue cycle management, which is crucial for healthcare facilities to maintain financial health.
- Before founding Ensemble, Ivy served as Vice President of Revenue Cycle at Health Management Associates, Inc., where valuable experience was gained in healthcare finance and operations.
- Prior to that role, Ivy held the position of Vice President at Community Health Systems, contributing to the effective management of regional service centers.
- Ivy’s career also includes experience as Business Office Director at Health Management Associates, where operational efficiencies were developed.
- Before transitioning to healthcare, Ivy worked as a certified broker at Prudential Financial, gaining extensive knowledge in financial services.
- Ensemble Health Partners has established a notable digital presence, with active engagement on platforms like LinkedIn, Facebook, and Twitter to reach potential clients and stakeholders.
- As CEO, Ivy has led the organization through a challenging yet rewarding period of establishing its brand and influence in the healthcare industry.
- Ensemble Health Partners is publicly traded on NASDAQ under the symbol ENSB, a milestone that reflects its growth and market credibility.